Pharmigene, Inc.(TW:7595)
NT$8.34+0.54 (+2.96%)
TW:7595
Pharmigene, Inc. Revenue
NT$8.34
At close:+0.54 (+2.96%)
Pharmigene, Inc. (7595) Revenue
Pharmigene, Inc. Revenue
Pharmigene, Inc. had a revenue of 68.66M in the quarter ending Jun 30, 2026, with -42.41%. This bring the company's revenue in the last twelve months to 187.88M, Decreased 6.01%. In the fiscal year ending Dec 31, 2025, Pharmigene, Inc. had annual revenue of 199.89M with 71.53% growth.
- Revenue (ttm)
- 187.88M
- Revenue Growth
- 25.80%
- P/S Ratio
- 2.11
- Revenue/Employee
- TWD 4,079,469
- Employees
- 49
- Market Cap
- TWD 420.88M
Revenue Chart
Pharmigene, Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 199.89M | 83.36M | 71.53% |
| Dec 31, 2024 | 116.53M | -16.17M | -12.19% |
| Dec 31, 2023 | 132.71M | -1.09M | -0.82% |
| Dec 31, 2022 | 133.80M | 4.45M | 3.44% |
| Dec 31, 2021 | 129.35M | 28.00M | 27.63% |
| Dec 31, 2020 | 101.35M | 36.07M | 55.26% |
| Dec 31, 2019 | 65.28M | -12.52M | -16.09% |
| Dec 31, 2018 | 77.80M | 22.85M | 41.58% |
| Dec 31, 2017 | 54.95M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.